Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 204-215

  Christie, Celia D C ^a,b,c   Steel Duncan, J ^a,b,c   Palmer, P ^a,b,c   Pierre, R ^a,b,c   Harvey, K ^c,d   Johnson, N ^a,b,c   Samuels, L A ^a,b,c   Dunkley Thompson, J ^a,b,c,e   Singh Minott, I ^a,c   Anderson, M ^a,b,c,f   Billings, C ^a,b,c,g   Evans Gilbert, T ^c,h   Rodriquez, B ^c,g   McDonald, C ^a,b,c,f   Moore, J ^a,b,c   Taylor, F ^a,b,c,h   Smikle, M F ^a,b,c   Williams, E ⁱ   Whorms, S ^a,b,c,d   Davis, D ^a,b,c   Mullings, A ^a,b,c   Morgan, O ^c,f   McDonald, D ^c,f   Alexander, G ^c,g   Onyonyor, A ^c,g   Hylton Kong, T ^c,j   Weller, P ^a,c   Harris, M ^j   Woodham, A ^k   Haughton, D D ^l   Carrington, D ^d   Figueroa, J P ^d   more..

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^c Kingston Paediatric and Perinatal HIV/AIDS Programme   (Jamaica)

^d National AIDS Programme   (Jamaica)

^e Mandeville Regional Hospital   (Jamaica)

^f Victoria Jubilee Maternity Hospital   (Jamaica)

^g Spanish Town Hospital ^*  (Jamaica)

^h Bustamante Hospital for Children   (Jamaica)

ⁱ National Institute of Public   (Jamaica)

^j Comprehensive Health Centre ^*  (Jamaica)

^k Saint Ann's Bay Hospital   (Jamaica)

^l May Pen Hospital   (Jamaica)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ARTICLE; CENTRAL AMERICA; CHILDHOOD DISEASE; EPIDEMIC; FAMILY; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; JAMAICA; LEADERSHIP; MEDICAL RESEARCH; NURSE; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COUNSELING; PEDIATRICIAN; PERINATAL MORBIDITY; PREGNANT WOMAN; PRENATAL CARE; QUALITY OF LIFE; SEROPREVALENCE; SHORT COURSE THERAPY; STUDENT; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CARIBBEAN REGION; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT WELFARE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERNATIONAL COOPERATION; JAMAICA; PEDIATRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGRAM DEVELOPMENT; PUBLIC HEALTH; SEROEPIDEMIOLOGIC STUDIES;

EID: 55949132953     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Joint United Nations Programmeme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. UNAIDS, May 2006. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport, accessed August 28, 2007.
2. Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G et al. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol 2007; 109: 1358-67.
3. D'Ippolito M, Read JS, Korelitz J, João EC, Mussi-Pinhata M, Rocha N for the NISDI Perinatal Study Group. Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study. Pediatr Infect Dis J 2007; 26: 649-53.
4. Gomez-Carrillo M, Pampuro S, Duran A, Losso M, Harris DR, Read JS for the NISDI Perinatal Study Group. Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries. AIDS Res Hum Retroviruses 2006; 22: 1186-91.
5. Duarte G, Read JS, Gonin R, Freimanis L, Ivalo S, Melo VH for the NISDI Perinatal Study Group. Mode of delivery and postpartum morbidity in Latin American and Caribbean countries among women who are infected with human immunodeficiency virus-1: the NICHD International Site Development Initiative (NISDI) Perinatal Study. Am J Obstet Gynecol. 2006 Jul; 195(1): 215-29. Epub 2006 May 3.
6. Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, for the NISDI Perinatal Study Group. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. AIDS 2007; 21: 199-205.
7. Szyld EG, Warley EM, Freimanis L, Gonin R, Cahn PE, Calvet GA for the NISDI Perinatal Study Group. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 2006; 20: 2345-53.
8. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, for the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Paediatrics. 2007 Mar; 119(3): e694-704. Epub 2007 Feb 12.
9. Kumar A, St White H, Carter AO. Trends in the uptake of antenatal voluntary counselling and testing for HIV and HIV prevalence among childbearing women in Barbados, 1993-2004: evidence to gauge the effectiveness of HIV prevention measures. West Indian Med J 2007; 56: 60-5.
10. Kumar A, Waterman I, Kumari G, Carter AO. Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected postparturient women in Barbados. AIDS Patient Care STDS 2006; 20: 724-30.
11. Kumar A, Rocheste E, Gibson M, Gibson T, Robinson H, Forde S. Antenatal voluntary counselling and testing for HIV in Barbados. Success and barriers to implementation. Rev Panam Salud Publica. 2004; 15: 242-8.
12. St John AM, Kumar A, Cave C. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados. Pediatr Infect Dis J 2003; 22: 422-6
13. Kumar A, St John MA, Lewis D. A descriptive study of HIV-infected long-term surviving children in Barbados - a preliminary report. West Indian Med J 2005; 54: 167-70.
14. González Náñez I, Díaz Jidy M, Pérez Avila J, Mengana Gutiérrez HL. [Antiretroviral therapy in HIV/ AIDS seropositive pregnant women in Cuba] Rev Cubana Med Trop 2004; 56: 70-2.
15. Gaillard EM, Boulos LM, André Cayemittes MP, Eustache L, Van Onacker JD, Duval N et al. Understanding the reasons for decline of HIV prevalence in Haiti. Sex Transm Infect. 2006; 82 Suppl 1: i14-20.
16. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353: 2325-34.
17. Perez-Then E, Peña R, Tavarez-Rojas M, Peña C, Quiñonez S, Buttler M, and the PMTCT Group. Preventing mother-to-child HIV transmission in a developing country: the Dominican Republic experience. J Acquir Immune Defic Syndr 2003; 34: 506-11.
18. Hutchinson GA, Jameson EM. Prevalence and risk factors for HIV infection in pregnant women in north Trinidad. West Indian Med J 2006; 55: 346-50.
19. Ministry of Health (MOH). National HIV/STI Prevention and Control Programme, Jamaica AIDS Report 2006, Kingston, Jamaica: MOH 2006. Available at: http://www.jamaica-nap.org, Accessed August 28, 2007.
20. Figueroa JP, Braithwaite A, Ward E, DuCasse M, Tscharf I, Nembhard O et al. The HIV/AIDS epidemic in Jamaica. AIDS 1995; 9: 761-8.
21. Figueroa JP. An overview of HIV/AIDS in Jamaica. Strenthening the response. West Indian Med J 2004; 53: 277-82.
22. Harvey KM, Figueroa JP, Tomlinson J, Gebre Y, Forbes S, Toyloy T et al. An assessment of mother-to-child transmission prevention in 16 pilot antenatal clinics in Jamaica. West Indian J Med 2004; 53: 293-6.
23. Christie CD, Bain B, Pierre R, Smikle M, Evans-Gilbert T, Fredericks J et al. HIV/AIDS in women, infants, children and adolescents in Jamaica: a further call to action. West Indian Med J 2001; 50: 258-62.
24. Christie CDC. A Paediatric and Perinatal HIV/AIDS Leadership Initiative in Kingston, Jamaica. West Indian Med J 2004; 53: 283-92.
25. Johnson N, Mullings A., Harvey K, Alexander G, McDonald D, Smikle M et al. HIV sero-prevalence, uptake of interventions to reduce mother to child transmission and birth outcomes in Greater Kingston, Jamaica. West Indian Med J 2004; 53: 297-302.
26. Rodriguez B, Steel-Duncan JC, Pierre R, Evans-Gilbert T, Hambleton I, Palmer P et al. Socio-demographic factors of HIV-exposed and HIV-infected Jamaican children. West Indian Med J 2004; 53: 303-7.
27. Steel-Duncan J, Pierre R, Evans-Gilbert T, Rodriquez B, Smikle M, Palmer P et al. Uptake of Interventions, Outcomes and Challenges in caring for HIV-exposed infants in Kingston, Jamaica. West Indian Med J 2004; 53: 308-14.
28. Pierre R, Steel-Duncan J, Evans-Gilbert T, Rodriguez B, Palmer P, Smikle M, et al. CDC-defined Diseases and Opportunistic Infections in Jamaican children with HIV/AIDS. West Indian Med J 2004; 53: 315-21.
29. Evans-Gilbert T, Pierre R, Steel-Duncan J, Rodriguez B, Whorms S, Palmer P et al. Anti-retroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53: 322-6.
30. Palmer P, Anderson-Allen MM, Billings CC, Moore JT, McDonald-Kerr C, Steel-Duncan JC et al. Nursing interventions in the Kingston Paediatric and Perinatal HIV/AIDS Programme. West Indian Med J 2004; 53: 327-31.
31. Walker E, Mayes B, Ramsay H, Hewitt H, Bain B, Christie CDC. Socio-demographic and Clinical Characteristics of Jamaican Adolescents with HIV/AIDS. West Indian Med J 2004; 53: 332-8.
32. Geoghagen M, Farr JA, Hambleton I, Pierre R, Christie CDC. HIV and TB Co-infections in Jamaican Children. West Indian Med J 2004; 53: 339-45.
33. Geoghagen M, Pierre R, Evans-Gilbert T, Rodriguez B, Christie CDC. TB, scabies and chicken pox outbreaks in an orphanage for children with HIV/ AIDS in Jamaica. West Indian Med J 2004; 53: 346-51.
34. Steel-Duncan JC, Pierre R, Evans-Gilbert T, Rodriguez B, Christie CDC. HIV/AIDS following sexual assault in Jamaican children and adolescents - a case for post exposure prophylaxis for HIV. West Indian Med J 2004; 53: 352-5.
35. Steel-Duncan J, Pierre R, Gabay L, Christie CDC. Nevirapine-associated rash in a Jamaican child. West Indian Med J 2004; 53: 356-8.
36. Feeney ME. HIV and children: The developing immune system fights back. West Indian Med J 2004; 53: 359-62.
37. Figueroa JP. The HIV epidemic in the Caribbean: meeting the challenges of delivering universal access to prevention, treatment and care. West Indian Med J 2008; 57: 195-203.
38. Christie CDC, Steel-Duncan J, Palmer P, Pierre R, Harvey K, Johnson N, et al. Paediatric and perinatal HIV/AIDS in Jamaica: an international leadership initiative, 2002-2007. West Indian Med J 2008; 57: 204-15.
39. Johnson N, Palmer P, Samuels LA, Morgan O, Onyonor A, Anderson M et al. Evolving care of HIV-infected pregnant women - From Nevirapine to HAART. West Indian Med J 2008; 57: 216-22.
40. Pierre R, Steel-Duncan J, Evans-Gilbert T, Rodriguez B, Moore J, Palmer P et al. Effectiveness of interventions in treating paediatric HIV/AIDS in Jamaican children. West Indian Med J 2008; 57: 223-30.
41. White YRG, Pierre RB, Steel-Duncan J, Palmer P, Evans-Gilbert T, Moore J et al. Predictors of Adherence to Antiretroviral Therapy in Jamaican Children with HIV/AIDS. West Indian Med J 2008; 57: 231-7.
42. Pryce C, Pierre R, Steel-Duncan J, Evans-Gilbert T, Palmer P, Moore J, et al. Safety of Antiretroviral Drug Therapy in Jamaican Children with HIV/AIDS. West Indian Med J 2008; 57: 238-45.
43. Steel-Duncan J, Miller M, Pierre R, Dunkley-Thompson J, Palmer P, Evans-Gilbert T et al. Renal Manifestations of HIV/AIDS in Jamaican Children. West Indian Med J 2008; 57: 246-52.
44. Barrett D, Steel-Duncan J, Eldemire-Shearer D, Christie CDC, Lindo J. Absence of opportunistic parasitic infestations among children living with HIV/AIDS in children's homes in Jamaica. West Indian Med J 2008; 57: 253-6.
45. Harrison A, Pierre R, Moore J, Davis D, Christie CDC. Clinical manifestations of adolescents with HIV/AIDS in Jamaica. West Indian Med J 2008; 57: 257-64.
46. Evans-Gilbert T, Steel-Duncan J, Pierre R, Rodriguez B, Palmer P, Figueroa JP et al. HIV-related mortality in Jamaican children. West Indian Med J 2008; 57: 265-8.
47. Moore J, Palmer P, Anderson-Allen M, Billings C, McDonald-Kerr C and the Kingston Paediatric and Perinatal HIV/AIDS Study Group. Voluntary Counselling and Testing in Antenatal Clinics in Greater Kingston, Jamaica. West Indian Med J 2008; 57: 269-73.
48. Weller PD, Hambleton I, Chambers C, Bain S, Christie CDC, Bain B. The voices of the women: Religious beliefs affecting compliance behavior among HIV positive women attending antenatal/postnatal clinics in urban Jamaica. West Indian Med J 2008; 57: 278-81.
49. Hylton-Kong T, Alveranga T, Norrine T, Harris H, Daubon G. Contact investigation in the prevention of mother-to-child transmission of HIV, comparing urban and rural outputs. West Indian Med J 2008; 57: 282-6.
50. + adolescents in Jamaica. West Indian Med J 2008; 57: 287-92.
51. Harvey K, Duncan J, Hirschorn L, Figueroa J P, Carrington D, Manning D et al. Evaluation of adherence to highly active antiretroviral therapy (HAART) in Jamaica. West Indian Med J 2008; 57: 293-7.
52. Singh-Minott I, Pierre R, Olugbuyi O, Dunkley-Thompson J, Haughton D, Christie CDC. Isoniazid-resistant disseminated tuberculosis in a Jamaican infant with HIV/AIDS. West Indian Med J 2008; 57: 298-301.
53. Dunkley-Thompson J, Pierre R, Steel-Duncan J, Palmer P, Davis D, Figueroa P et al. Bacille Calmette-Guérin Lymphadenitis following antiretroviral therapy in Jamaican infants with rapid progressor HIV disease. West Indian Med J 2008; 57: 302-6.
54. Lowe GA, Gibson RC, Christie CDC. HIV infection, sexual abuse and social support in Jamaican adolescents referred to a psychiatric service. West Indian Med J 2008; 57: 307-11.
55. Billings C, the Kingston Paediatric and Perinatal HIV/AIDS Study Group. Tattooing and perinatal HIV/AIDS in Jamaica. West Indian Med J 2008; 57: 312-14.
56. Brissett D, Griffiths-Irving J. Speak up! Speak out! Building HIV and AIDS awareness among Jamaican children. West Indian Med J 2008; 57: 315-20.
57. Byam PR, Pierre RB, Christie CDC, Andiman WA and KPAIDS Study Group. Cotrimoxazole-resistant invasive bacterial infections in Jamaican Children with HIV/AIDS. Oral platform presentation, Annual Research Conference, Faculty of Medical Sciences, UWI, Nov, 2007, West Indian Med J, 2007; 56;5; abstract O-23 and 18th International AIDS Conference, Mexico City, 2008.
58. Dunkley-Thompson J, Figueroa JP, Christie CDC. The "missed" population of perinatally HIV-infected adolescent slow progressors in Jamaica. West Indian Med J 2006; 55: 295-7.
59. Mussi-Pinhata M, Motta F, Friemann L, DeSouza R, Szyld F, Succi R et al. Lower Respiratory Tract Infections and Hospitalizations Among HIV-Exposed, Uninfected Infants Born in Latin America. Poster presentation, Session 4467 - Infectious Diseases, Academic Paediatric Societies, Annual Conference, Honolulu, Hawaii, May 3-8, 2008. (Abstract #: 750776).
60. Pierre RB, Singh-Minott I, Moore J, Carrington D, Harvey K, Smikle M et al. Failure of antiretroviral therapy (ART) in Jamaican children: Issues for the WHO approach in developing countries. Poster presentation and Abstract, 18th International AIDS Conference, Mexico, August 3-8, 2008.
61. Rodriquez L, White S, Frankson MA, Billings C, Christie CDC and the Kingston Paediatric and Perinatal HIV/AIDS Programme (KPAIDS) Research Group. Factors influencing repeat pregnancies in HIV-positive mothers in Jamaica. D18 - Social and cultural factors influencing HIV vulnerability and prevention. Poster presentation and Abstract # A-072-0204-04630, 18th International AIDS Conference, Mexico, August 3-8, 2008.
62. Lewis K, Pierre R, Frankson MA, Christie CDC and Kingston Paediatric and Perinatal HIV/AIDS Programme (KPAIDS) Research Group. Hematological manifestations of HIV/AIDS in an antiretroviral drug naive paediatric cohort. Abstract, 18th International AIDS Conference, Mexico, August 3-8, 2008.
63. Feeney F, Goudy B, Steel-Duncan J, Rathod A, Burchett S, McIntosh K et al. Spontaneous Control of HIV-1 Following Perinatal Infection Is Associated with IL-2 Secretion by CD8+ T Cells. Committee on Retroviruses and Opportunistic Infections (CR01), Poster and Abstract D-172; Denver, Colorado; Feb, 2006.
64. Schneidewind A, Tang Y, Ryland EG, Huang S, Dunkley-Thompson J, Steel-Duncan JC et al. Control of viremia in B57+ infants is mediated by fitness-attenuating mutations. HIV Vaccine Conference, Cape Town, South Africa, Oct 13-16, 2008.
65. Jeweler's For Children commits $4.7 million USD's to children's charities. http.//www.jckonline.com/article/ CA6453088.html?industryid=46015&q=JCK%2C+Margaret+Feeney. Accessed September 25, 2007.
66. "Equal treatment for children: Turning the tide of the Paediatric AIDS Pandemic". United States Congressional Subcommittee Briefing and Press Conference, in the Russell Senate Office Building, Capitol Hill, Washington DC, USA; Co-sponsored by Senator Hillary Clinton (Democrat of New York) and Richard Lugar (Republican of Indiana), Elizabeth Glaser Paediatric AIDS Foundation, and the Global Health Council, 26 July, 2006; www.usinfo.state.gov/xarchives/ display.html?p=washfile-english&y=2006&m=July&x= 20060727161825ajesrom5.086917e-02; www.pedaids.org/News/AdvocacyNews/ Other/Congressional%20Briefing%20Highlig.aspx; www.globalhealth.org/ news/article/7667. Accessed September 25, 2007.
67. "A perspective from the field: the value of collaborative research partnerships", Briefing on The critical Link between Research and implementation: staying on the cutting edge of combating HIV/AIDS in the USA and abroad and a Commitment to Children on World AIDS Day luncheon, to honor Secretary of Health, Tommy Thompson, Senator Thomas Daschle and Senator Mike Dewine, co-sponsored by the Elizabeth Glaser Paediatric AIDS and Pfizer Foundations. Capitol Hill, Washington DC, Dec 1, 2004.
68. Second C. Davenport Cook Lectureship in International Child Health, titled "Academic Paediatrics in Jamaica" delivered at Yale University School of Medicine, Paediatric Grand Rounds, New Haven, Connecticut, USA, October 5, 2005.
69. PMTCT+ - Integrating Treatment Care and Support with prevention of mother-to-child transmission of HIV services. Implementation guidelines for Healthcare workers. National HIV/STI Programmeme, Ministry of Health - Jamaica, 2006.
70. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: toward universal access. Recommendations for a public health approach. Avaibale at: www.who.org. Accessed September 22, 2007.
71. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z et al. Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 2006; 354: 75-7.
72. Vesikari T, Itzler R, Matson D, Santosham M, Christie CDC, Coia M et al. Efficacy of a Pentavalent Rotavirus Vaccine in Reducing Rotavirus-Associated Healthcare Utilization Across three Regions and eleven Countries. Int J Infect Dis 2007; 11 Suppl 2: S29-35
73. Christie CDC, Duncan ND, Thame KT, Onorato MT, Smith H, Malcolm L et al. Pentavalent Human-Bovine Reassortant Rotavirus Vaccine (PRV) Reduced Healthcare Resource Utilization (HCRU) in Jamaican Infants of African Descent from Low-Middle Income Families. Vaccines for Enteric Diseases Conference, Pestana Palace Hotel, Lisbon, Portugal, April 25-27, 2007; Session 4 - Rotavirus Vaccines II; Oral presentation; Abstract # VED 111.
74. Christie CDC. Multivalent Protection Against a Severe Paediatric Disease - Rotavirus. Merck, Sharpe and Dohme Symposium - New Generation Vaccines Designed To Do More. 13thInternational Congress on Infectious Diseases; Kuala Lumpur, Malaysia, June 21, 2008.
75. Christie CDC and Avilla L. Review of Global and Regional Recommendations For The Pentavalent Rotavirus Vaccine and Quadrivalent Human Papilloma Virus Vaccine. Merck, Sharpe and Dohme Symposium - New Generation Vaccines Designed To Do More. 13th International Congress on Infectious Diseases, Kuala Lumpur, Malaysia, June 21, 2008.
76. AAP policy statement. Increasing antiretroviral drug access for children with HIV infection. www.paediatrics.org/cgi/doi/10.1542/ peds.2007-0273. Accessed September 22, 2007.